JWS stock has traded at between $9.95 and $17.43 since its debut. It’s currently 46 percent above its low and 17 percent below its peak. As Wall Street hasn’t started tracking the stock, analysts haven’t yet given a target price. However, Cano’s stock forecast looks bullish.
Founded in 2009, Cano Health offers value-based care to over 103,000 members through a network of 564 primary care physicians across 14 areas in Texas, Nevada, Florida, and Puerto Rico. The company expects to reach 300,000 members by 2023. If forecasts sales of $1.45 billion in 2021, and sees them growing by 56 percent in 2022 and 39 percent in 2023. The company also expects adjusted EBITDA of $195 million in 2023, compared with $70 million in 2020.
View more information: https://marketrealist.com/p/cano-health-forecast-after-jws-merger-date/